<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(9)</volume><submitter>Messaaoui A</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>To assess the impact of real-time continuous glucose monitoring (RT-CGM) instead of first-generation flash glucose monitoring (FGM) on hypoglycaemia in children and adolescents with type 1 diabetes.&lt;h4>Methods&lt;/h4>In this randomized controlled interventional study, young individuals with type 1 diabetes used RT-CGM or FGM for 8 weeks. We evaluated changes in time below range (TBR), severe hypoglycaemia (SH), HbA1c, glycaemic variability, and impaired awareness of hypoglycaemia with RT-CGM (intervention group) in comparison with FGM.&lt;h4>Results&lt;/h4>We randomly assigned 37 participants to either the intervention group (n = 19) or the control group (n = 18). At 8 weeks, we did not find a decrease in TBR in either group, but there was a significant reduction in SH in the intervention group. For participants with TBR ≥ 5% at baseline, we observed significant reductions in 24-h TBR, wake TBR, sleep TBR, and glucose variability at 8 weeks in the intervention group.&lt;h4>Conclusions&lt;/h4>The use of RT-CGM versus FGM decreased SH in young individuals with type 1 diabetes, and TBR and glucose variability in patients with a higher TBR at baseline. The patient's history should be taken into account when advising on the method of blood glucose monitoring, as RT-CGM could be more effective in younger patients at high risk for SH.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov NCT04249102.</pubmed_abstract><journal>Diabetes therapy : research, treatment and education of diabetes and related disorders</journal><pagination>1671-1681</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9399330</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial.</pubmed_title><pmcid>PMC9399330</pmcid><pubmed_authors>Messaaoui A</pubmed_authors><pubmed_authors>Tenoutasse S</pubmed_authors><pubmed_authors>Hajselova L</pubmed_authors><pubmed_authors>Crenier L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial.</name><description>&lt;h4>Introduction&lt;/h4>To assess the impact of real-time continuous glucose monitoring (RT-CGM) instead of first-generation flash glucose monitoring (FGM) on hypoglycaemia in children and adolescents with type 1 diabetes.&lt;h4>Methods&lt;/h4>In this randomized controlled interventional study, young individuals with type 1 diabetes used RT-CGM or FGM for 8 weeks. We evaluated changes in time below range (TBR), severe hypoglycaemia (SH), HbA1c, glycaemic variability, and impaired awareness of hypoglycaemia with RT-CGM (intervention group) in comparison with FGM.&lt;h4>Results&lt;/h4>We randomly assigned 37 participants to either the intervention group (n = 19) or the control group (n = 18). At 8 weeks, we did not find a decrease in TBR in either group, but there was a significant reduction in SH in the intervention group. For participants with TBR ≥ 5% at baseline, we observed significant reductions in 24-h TBR, wake TBR, sleep TBR, and glucose variability at 8 weeks in the intervention group.&lt;h4>Conclusions&lt;/h4>The use of RT-CGM versus FGM decreased SH in young individuals with type 1 diabetes, and TBR and glucose variability in patients with a higher TBR at baseline. The patient's history should be taken into account when advising on the method of blood glucose monitoring, as RT-CGM could be more effective in younger patients at high risk for SH.&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov NCT04249102.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2024-11-06T17:49:44.871Z</modification><creation>2024-11-06T17:49:44.871Z</creation></dates><accession>S-EPMC9399330</accession><cross_references><pubmed>35870074</pubmed><doi>10.1007/s13300-022-01297-x</doi></cross_references></HashMap>